Intradigm Corporation's Merger

Intradigm Corporation raised a round of funding on December 16, 2009. Investors include Silence Therapeutics.

Intradigm is a private biotechnology company focused on the discovery, development and delivery of novel targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases. …

Articles about Intradigm Corporation's Merger: